← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
145 та иш
Иш: Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity
Targeting non-coding RNAs to overcome cancer therapy resistance
Baoqing Chen, Mihnea P. Dragomir, Yang Chen +3
Шарҳ мақола20224 иқтибосABILIN28/ <i>let-7</i> /PD-L1 Pathway as a Target for Cancer Immunotherapy
Yanlian Chen, Chen Xie, Xiaohui Zheng +4
Мақола20193 иқтибосABICircRNAs: role in human diseases and potential use as biomarkers
Lorena Verduci, Emilio Tarcitano, Sabrina Strano +2
Шарҳ мақола20213 иқтибосABINon‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
Шарҳ мақола20233 иқтибосABIMechanisms of Tumor Cell–Intrinsic Immune Evasion
Stefani Spranger, Thomas F. Gajewski
Мақола20172 иқтибосABIMir-21 Suppression Promotes Mouse Hepatocarcinogenesis
Marta Correia de Sousa, Nicolas Calo, Cyril Sobolewski +12
Мақола20212 иқтибосABIThe role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen +2
Шарҳ мақола20212 иқтибосABIThe role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang +2
Шарҳ мақола20242 иқтибосABINoncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
Le Zhang, Xiaonan Xu, Xiulan Su
Шарҳ мақола20202 иқтибосABI